Skip to main content
. 2023 Apr 4;15(4):1138. doi: 10.3390/pharmaceutics15041138

Figure 4.

Figure 4

Summary of findings comparing IA and IV delivery of radiopharmaceuticals to tumors. The ratios from all studies were averaged, and the standard deviation of the average is reported here. The authors of the corresponding studies are as follows: Kratochwil et al. (Y-90-DOTATOC) [40], Thakral et al. (Lu-177-DOTATATE) [42], Sayman et al. (Lu-177-PSMA) [43], Verburg et al. (Ga-68-DOTATATE) [44], and Vonken et al. (Lu-177-HA-DOTATATE) [45].